HUMANA INC.

(HUM)
  Report
Real-time Estimate Cboe BZX  -  05/26 11:20:41 am EDT
448.94 USD   +0.95%
10:44aWells Fargo Adjusts Humana's Price Target to $514 from $512, Keeps Overweight Rating
MT
05/20Humana Wins Competition Clearance To Acquire Swedish Assistance Provider
MT
05/19Humana Focused on Returning to Leading Medicare Advantage Growth, Sees Margin Improvement, UBS Says
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 48 53754 29659 62255 710--
Enterprise Value (EV)1 50 14956 28368 72262 10661 06461 282
P/E ratio 18,2x16,2x20,5x18,8x16,2x14,3x
Yield 0,60%0,61%0,59%0,69%0,76%1,17%
Capitalization / Revenue 0,75x0,70x0,72x0,60x0,55x0,50x
EV / Revenue 0,77x0,73x0,83x0,67x0,61x0,55x
EV / EBITDA 13,6x13,3x21,5x12,4x10,9x10,1x
Price to Book 4,02x3,85x3,73x3,36x2,89x2,54x
Nbr of stocks (in thousands) 132 426132 341128 534126 493--
Reference price (USD) 367410464440440440
Announcement Date 02/05/202002/03/202102/02/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 64 88877 15583 06492 966100 866110 937
EBITDA1 3 6974 2403 2015 0095 6016 090
Operating profit (EBIT)1 3 2623 7512 4884 3524 8185 335
Operating Margin 5,03%4,86%3,00%4,68%4,78%4,81%
Pre-Tax Profit (EBT)1 3 4564 6003 3543 9114 5094 935
Net income1 2 7073 3672 9332 9693 4133 831
Net margin 4,17%4,36%3,53%3,19%3,38%3,45%
EPS2 20,125,322,723,427,230,9
Dividend per Share2 2,202,502,733,043,355,17
Announcement Date 02/05/202002/03/202102/02/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 20 69721 05423 97023 38522 93622 707
EBITDA1 1 0404341 6041 5281 311644
Operating profit (EBIT)1 8902401 4151 3391 151489
Operating Margin 4,30%1,14%5,90%5,73%5,02%2,16%
Pre-Tax Profit (EBT)1 1 636-60,01 2201 266956496
Net income1 1 531-14,0930956764323
Net margin 7,40%-0,07%3,88%4,09%3,33%1,42%
EPS2 11,8-0,117,297,536,062,54
Dividend per Share ------
Announcement Date 11/03/202102/02/202204/27/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 1 6121 9879 1006 3965 3545 572
Net Cash position1 ------
Leverage (Debt / EBITDA) 0,44x0,47x2,84x1,28x0,96x0,91x
Free Cash Flow1 4 5484 6759462 8094 2695 822
ROE (Net Profit / Equities) 21,7%19,4%17,9%19,0%19,3%18,8%
Shareholders' equity1 12 47917 39216 36815 63217 70720 405
ROA (Net Profit / Asset) 8,84%12,8%7,39%6,77%7,38%8,27%
Assets1 30 63326 22439 66443 85246 23446 333
Book Value Per Share2 91,1107124131153174
Cash Flow per Share2 39,242,417,531,638,949,3
Capex1 7369641 3161 3291 4341 424
Capex / Sales 1,13%1,25%1,58%1,43%1,42%1,28%
Announcement Date 02/05/202002/03/202102/02/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 55 710 224 108
Net sales (USD) 83 064 000 000
Number of employees 95 500
Sales / Employee (USD) 869 780
Free-Float 63,6%
Free-Float capitalization (USD) 35 409 181 069
Avg. Exchange 20 sessions (USD) 417 623 651
Average Daily Capital Traded 0,75%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA